Ashlee Mattingly

FDA Grant Tasks M-CERSI with Reviewing Substances Compounded by Outsourcing Facilities

January 1, 2022

M-CERSI receives grant to study how drug ingredients are combined, mixed, or altered to create tailored medication.

SOP’s Mattingly Awarded $2.2 Million Grant to Investigate Bulk Drug Substances for Compounding

December 4, 2018

Grant from the U.S. Food and Drug Administration will span three years and include evaluations for more than 200 nominated substances.